mhurhangee/ep-ind-claims huggingface dataset:
A method for transmitting packets over a radio link, wherein said radio link connects a first network element and a second network element, and at least a first packet and a second packet comprise a respective dynamic datum including a respective packet's portion whose value is not pre-defined according to any protocol used for transmitting the packets, wherein said method comprises, at said first network element: a) associating said dynamic datum of said first packet to a datum identifier (L_ID, L_ID), wherein said datum identifier (L_ID, L_ID) is of a lower bit length than said dynamic datum of said first packet; b) adding said datum identifier (L_ID, L_ID) to said first packet; and c) if the dynamic datum of said second packet corresponds to the dynamic datum of said first packet, replacing, within said second packet, said dynamic datum with said datum identifier (L_ID, L_ID). a) associating said dynamic datum of said first packet to a datum identifier (L_ID, L_ID), wherein said datum identifier (L_ID, L_ID) is of a lower bit length than said dynamic datum of said first packet; b) adding said datum identifier (L_ID, L_ID) to said first packet; and c) if the dynamic datum of said second packet corresponds to the dynamic datum of said first packet, replacing, within said second packet, said dynamic datum with said datum identifier (L_ID, L_ID).
A method comprising: determining, at a control server that is remote relative to one or more DNS clients (110, 120), performance data of one or more first DNS servers (132, 152) to which the one or more DNS clients send DNS resolution requests, wherein determining the performance data comprises receiving, from a first DNS client, first performance data regarding the performance of the one or more DNS servers and wherein the performance data includes the first performance data; based on the performance data, sending, from the control server to the one or more DNS clients, configuration data that, when processed by the one or more DNS clients, causes a configuration of each of the one or more DNS clients to change; wherein the configuration data indicates one or more second DNS servers that are different than the one or more first DNS servers; wherein the configuration data cause the one or more DNS clients to use the one or more second DNS servers to resolve one or more subsequent DNS resolution requests. determining, at a control server that is remote relative to one or more DNS clients (110, 120), performance data of one or more first DNS servers (132, 152) to which the one or more DNS clients send DNS resolution requests, wherein determining the performance data comprises receiving, from a first DNS client, first performance data regarding the performance of the one or more DNS servers and wherein the performance data includes the first performance data; based on the performance data, sending, from the control server to the one or more DNS clients, configuration data that, when processed by the one or more DNS clients, causes a configuration of each of the one or more DNS clients to change; wherein the configuration data indicates one or more second DNS servers that are different than the one or more first DNS servers; wherein the configuration data cause the one or more DNS clients to use the one or more second DNS servers to resolve one or more subsequent DNS resolution requests.
A method of decoding downlink control information, DCI, by a user equipment, UE, in a wireless communication system, the method comprising: receiving the DCI from a base station; and decoding the DCI, wherein based on the DCI activating or releasing a sidelink semi-persistent scheduling, SPS, between the UE and another UE for a Vehicle-to-Everything, V2X, communication, the DCI comprises (i) a sidelink SPS activation/release field and (ii) a sidelink SPS configuration index field, wherein the sidelink SPS configuration index field informs a specific sidelink SPS configuration and the sidelink SPS activation/release field informs an activation or release for the specific sidelink SPS configuration, the method being characterized in that a plurality of sidelink SPS configurations is configured to the UE, and wherein the sidelink SPS configuration index field informs the specific sidelink SPS configuration among the plurality of sidelink SPS configurations. receiving the DCI from a base station; and decoding the DCI, wherein based on the DCI activating or releasing a sidelink semi-persistent scheduling, SPS, between the UE and another UE for a Vehicle-to-Everything, V2X, communication, the DCI comprises (i) a sidelink SPS activation/release field and (ii) a sidelink SPS configuration index field, wherein the sidelink SPS configuration index field informs a specific sidelink SPS configuration and the sidelink SPS activation/release field informs an activation or release for the specific sidelink SPS configuration, the method being characterized in that a plurality of sidelink SPS configurations is configured to the UE, and wherein the sidelink SPS configuration index field informs the specific sidelink SPS configuration among the plurality of sidelink SPS configurations.
A method for determining in a sample the total amount of a ligand of a therapeutic antibody comprising the following steps in the following order: - subjecting the sample to an acid treatment, - forming in solution a ternary complex comprising i) an anti-ligand antibody, ii) the ligand, and iii) labelled therapeutic antibody, by adding first an excess of labelled therapeutic antibody to the sample and incubating the acid-treated sample with the excess of labelled therapeutic antibody to form a binary labelled therapeutic antibody-ligand complex, and by adding after the formation of the binary complex the polyclonal anti-ligand antibody to the sample to form a ternary labelled therapeutic antibody-ligand-anti-ligand antibody complex, and - determining the amount of the ternary complex, and thereby determining the amount of the ligand of the therapeutic antibody. - subjecting the sample to an acid treatment, - forming in solution a ternary complex comprising i) an anti-ligand antibody, ii) the ligand, and iii) labelled therapeutic antibody, by adding first an excess of labelled therapeutic antibody to the sample and incubating the acid-treated sample with the excess of labelled therapeutic antibody to form a binary labelled therapeutic antibody-ligand complex, and by adding after the formation of the binary complex the polyclonal anti-ligand antibody to the sample to form a ternary labelled therapeutic antibody-ligand-anti-ligand antibody complex, and i) an anti-ligand antibody, ii) the ligand, and iii) labelled therapeutic antibody, - determining the amount of the ternary complex,
A device (100, 200, 300) for securing and retaining an optical cable, said optical cable mainly extending along a longitudinal direction and comprising optical fiber units, flexible strength members and an outer sheath, said device (100, 200, 300) comprising: a reel (117, 217, 317) configured to receive at least one turn of said strength members; and a clip (150, 250, 350) configured to cooperate with said reel (117, 217, 317) for maintaining said at least one turn of said strength members around said reel, characterized in that said device further comprises a belay element (116, 216, 316) configured to deviate said flexible strength members of the optical cable from said longitudinal direction towards said reel (117, 217, 317). a reel (117, 217, 317) configured to receive at least one turn of said strength members; and a clip (150, 250, 350) configured to cooperate with said reel (117, 217, 317) for maintaining said at least one turn of said strength members around said reel,
An analogue of Stichodactyla helianthus toxin ShK comprising an ShK toxin polypeptide and an N -terminal extension comprising an amino acid sequence according to formula: a -X -4 X -3 X -2 X -1 - b (SEQ ID NO: 3), wherein X -4 is D, E or other negatively-charged amino acid or derivative thereof, X -3 is E, I, L, S, V, W or a tryptophan derivative, X -2 is S or T, X -1 is S or T, a is absent or a first additional moiety, and b is absent or a second additional moiety, wherein the analogue is capable of blocking the activation of potassium channels Kv 1.3. X -4 is D, E or other negatively-charged amino acid or derivative thereof, X -3 is E, I, L, S, V, W or a tryptophan derivative, X -2 is S or T, X -1 is S or T, a is absent or a first additional moiety, and b is absent or a second additional moiety,
A compound of formula 1a wherein: R 1, R 2, R 3, R 4, and R 5 are selected from H, halo, halogenated C 1-4 alkyl, and cyano; and R 6 is selected from H, a residue of an amino acid, formyl, glyoxyloyl, thioformyl, carbamoyl, thiocarbamoyl, sulfamoyl, sulfinamoyl, carboxy, sulfo, phosphono, and wherein R a 1 and R b 1 may be the same or different and represent a hydrocarbon group or a heterocyclic group, or R a 1 and R b 1 combine to each other, together with the nitrogen atom to which they bind, to form a cyclic amino group; in free or pharmaceutically acceptable salt form, for use as a medicament in the treatment of an aquaporin-mediated disease or condition by inhibiting aquaporin-2 and/or aquaporin-4, wherein the aquaporin-mediated disease or condition is selected from myocardial ischemia, myocardial infarction, myocardial hypoxia, and congestive heart failure. R 1, R 2, R 3, R 4, and R 5 are selected from H, halo, halogenated C 1-4 alkyl, and cyano; and R 6 is selected from H, a residue of an amino acid, formyl, glyoxyloyl, thioformyl, carbamoyl, thiocarbamoyl, sulfamoyl, sulfinamoyl, carboxy, sulfo, phosphono, and wherein R a 1 and R b 1 may be the same or different and represent a hydrocarbon group or a heterocyclic group, or R a 1 and R b 1 combine to each other, together with the nitrogen atom to which they bind, to form a cyclic amino group; in free or pharmaceutically acceptable salt form, for use as a medicament in the treatment of an aquaporin-mediated disease or condition by inhibiting aquaporin-2 and/or aquaporin-4, wherein the aquaporin-mediated disease or condition is selected from myocardial ischemia, myocardial infarction, myocardial hypoxia, and congestive heart failure.
Shell and tube heat exchanger, comprising a housing through which a fluid flows during operation, and comprising a tube bundle which is arranged in the housing and through which a fluid flows during operation, the tube bundle having a separation point at which it can be separated into a short tube bundle and a long tube bundle, and the separation point having a double flange having two flanges (9, 10) connected in a fluid-tight manner, characterised in that tubes of each tube bundle (7, 8) are connected to one flange (9, 10) in a fluid-tight manner.
An interface system for a mechanical decoupling of an interface body and a cooling pipe of a cooling system for a battery cell or battery module of a vehicle, the interface system comprising: a housing for a battery cell or a battery module; an inset having a first side and a second side opposite to the first side; an interface body having a first end and a second end and further having a bore-hole with a first opening on the first end and a second opening on the second end; wherein the housing comprises a part having a hole; wherein the inset comprises a recess in the second side to receive the interface body; wherein the interface body is at least partially insertable into the inset such that, when the interface body is inserted into the inset, the first end of the interface body is located in the recess of the inset; wherein the inset is at least partially insertable, into the part through the hole such that, when the inset is inserted into the part, the first side of the inset is located inside the housing; wherein the first side of the inset comprises a hole allowing access to the first opening of the bore-hole of the interface body when the interface body is inserted into the inset; and wherein the first opening of the bore-hole through the interface body is adapted to receive, in a slidable manner, an inlet of the cooling pipe, and the second opening of the bore-hole is connectable, in a fluid-tight manner, with an external cooling supply or cooling discharge. a housing for a battery cell or a battery module; an inset having a first side and a second side opposite to the first side; an interface body having a first end and a second end and further having a bore-hole with a first opening on the first end and a second opening on the second end; wherein the housing comprises a part having a hole; wherein the inset comprises a recess in the second side to receive the interface body; wherein the interface body is at least partially insertable into the inset such that, when the interface body is inserted into the inset, the first end of the interface body is located in the recess of the inset; wherein the inset is at least partially insertable, into the part through the hole such that, when the inset is inserted into the part, the first side of the inset is located inside the housing; wherein the first side of the inset comprises a hole allowing access to the first opening of the bore-hole of the interface body when the interface body is inserted into the inset; and wherein the first opening of the bore-hole through the interface body is adapted to receive, in a slidable manner, an inlet of the cooling pipe, and the second opening of the bore-hole is connectable, in a fluid-tight manner, with an external cooling supply or cooling discharge.
A terminal device, comprising: a radio interface operative to receive a broadcast message from a cellular network (30, 40), the broadcast message including at least one parameter associated with coverage enhancement, CE, operation of the terminal device (11, 12; 20) and to perform a CE level dependent repetition of a random access preamble transmission (93, 94); and an electronic circuit operative to control, when the terminal device (11, 12; 20) is in CE operation and based on the at least one parameter included in the broadcast message, a CE-level dependent backoff behavior for the CE level dependent repetition of the random access preamble transmission (93, 94), characterised in that, the at least one parameter indicates which CE level is affected by a potential congestion situation. a radio interface operative to receive a broadcast message from a cellular network (30, 40), the broadcast message including at least one parameter associated with coverage enhancement, CE, operation of the terminal device (11, 12; 20) and to perform a CE level dependent repetition of a random access preamble transmission (93, 94); and an electronic circuit operative to control, when the terminal device (11, 12; 20) is in CE operation and based on the at least one parameter included in the broadcast message, a CE-level dependent backoff behavior for the CE level dependent repetition of the random access preamble transmission (93, 94), characterised in that, the at least one parameter indicates which CE level is affected by a potential congestion situation.
A communication device comprising: multiple electronic components (4a, 4b) of different thickness; a circuit substrate provided with the multiple electronic components; a bottom plate that fixes the circuit substrate; an antenna provided in the circuit substrate; and a sealing member that covers the circuit substrate, wherein the electronic components include a first electronic component, and a second electronic component that has a thickness greater than the first electronic component in a direction perpendicular to the circuit substrate, and characterized in that the first electronic component is arranged at a vicinity of the antenna, and is covered with the sealing member to a first height, and the second electronic component is arranged at a position away from the antenna by a predetermined distance to be further away from the antenna than the first electronic component is from the antenna, and the second electronic component is covered with the sealing member to a second height, where the first height is lower than the second height. multiple electronic components (4a, 4b) of different thickness; a circuit substrate provided with the multiple electronic components; a bottom plate that fixes the circuit substrate; an antenna provided in the circuit substrate; and a sealing member that covers the circuit substrate, wherein the electronic components include a first electronic component, and a second electronic component that has a thickness greater than the first electronic component in a direction perpendicular to the circuit substrate, and characterized in that the first electronic component is arranged at a vicinity of the antenna, and is covered with the sealing member to a first height, and the second electronic component is arranged at a position away from the antenna by a predetermined distance to be further away from the antenna than the first electronic component is from the antenna, and the second electronic component is covered with the sealing member to a second height, where the first height is lower than the second height.
An isolated antigen binding protein comprising an immunoglobulin heavy chain variable region and an immunoglobulin light chain variable region, wherein the heavy chain variable region comprises the amino acid sequence of SEQ ID NO: 254 and the light chain variable region comprises the amino acid sequence of SEQ ID NO: 234.
A dual transgenic mouse having a gulonolactone oxidase gene knockout (GULO-/-), a functional human apolipoprotein B-100 gene (apo( B-100) +) and a functional human apolipoprotein (a) gene (apo (a) +) that produces human lipoprotein (a) and produces no Vitamin C, wherein said transgenic mouse is obtained by: crossbreeding a first knockout strain mouse-and a second strain of transgenic mouse expressing a set of genes that are human in nature, wherein the first knockout strain mouse comprises a non-functional gulonolactone oxidase gene, GULO gene (GULO-/-), and produces no Vitamin C, wherein the second strain of mouse possesses a human apolipoprotein (a) gene (apo (a) +), to obtain a third strain of transgenic mouse, wherein the third strain of transgenic mouse expresses the human apo (a) gene (apo (a) +) and comprises a non-functional GULO gene (GULO-/-); and crossbreeding the first knockout strain mouse comprising a non-functional GULO gene and a fourth strain of mouse possessing a human apolipoprotein B-100 gene (apo B-100 +), to obtain a fifth strain of mouse, wherein the fifth strain of mouse comprises a non-functional GULO gene (GULO-/-) and expresses the human apo B-100 gene (apo B-100 +); and crossbreeding the third strain of mouse comprising a non-functional GULO gene (GULO-/-) and expressing the human apo (a) gene (apo (a) +), and the fifth strain of transgenic mouse comprising a non-functional GULO gene (GULO-/-) and possessing the human apo B-100 gene (apo B-100 +) to obtain the dual transgenic mouse comprising a non-functional GULO gene (GULO-/-) and which, simultaneously, produces human lipoprotein (a) (Lp(a)+) and produces no Vitamin C. crossbreeding a first knockout strain mouse-and a second strain of transgenic mouse expressing a set of genes that are human in nature, wherein the first knockout strain mouse comprises a non-functional gulonolactone oxidase gene, GULO gene (GULO-/-), and produces no Vitamin C, wherein the second strain of mouse possesses a human apolipoprotein (a) gene (apo (a) +), to obtain a third strain of transgenic mouse, wherein the third strain of transgenic mouse expresses the human apo (a) gene (apo (a) +) and comprises a non-functional GULO gene (GULO-/-); and crossbreeding the first knockout strain mouse comprising a non-functional GULO gene and a fourth strain of mouse possessing a human apolipoprotein B-100 gene (apo B-100 +), to obtain a fifth strain of mouse, wherein the fifth strain of mouse comprises a non-functional GULO gene (GULO-/-) and expresses the human apo B-100 gene (apo B-100 +); and crossbreeding the third strain of mouse comprising a non-functional GULO gene (GULO-/-) and expressing the human apo (a) gene (apo (a) +), and the fifth strain of transgenic mouse comprising a non-functional GULO gene (GULO-/-) and possessing the human apo B-100 gene (apo B-100 +) to obtain the dual transgenic mouse comprising a non-functional GULO gene (GULO-/-) and which, simultaneously, produces human lipoprotein (a) (Lp(a)+) and produces no Vitamin C.
An audio signal amplifying and processing unit, comprising: an input for audio signals; an audio signals processor; an output for a signal for driving an electro-acoustic transducer; and characterized by comprising an input for a differential-pressure signal between the pressure of the front space and that of the rear space of said acoustic transducer; wherein the differential-pressure signal is processed by said processor for correcting distortions and incongruities regarding a reference acoustic system via variation of the signal for driving the electro-acoustic transducer.
Method for connecting an electrical component to a busbar, in particular to a laminated busbar, wherein the busbar is configured for mounting the electronic component on the busbar and has at least one plug-in region configured for inserting a contact element of the electronic component, in particular a pin of the electronic component, into the at least one plug-in region, wherein the at least one plug-in region is formed as a recessed plug-in region, comprising: - inserting a contact element into the at least one plug-region and - using a soldering and/or brazing material for soldering the contact element to the busbar, wherein the recessed plug-in region is filled with the soldering and/or brazing material without protruding from an outer surface of the busbar in a finished state, wherein the outer surface faces away from the electronic component. - inserting a contact element into the at least one plug-region and - using a soldering and/or brazing material for soldering the contact element to the busbar,